Related Experiment Video

Updated: Aug 17, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 23, 2010

Rho proteins and cancer

Anne J Ridley1

  • 1Department of Biochemistry and Molecular Biology, Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, University College London, London, UK. anne@ludwig.ucl.ac.uk

Breast Cancer Research and Treatment
|March 5, 2004
PubMed

Insights

Rho GTPases are crucial for cell functions and gene expression, impacting cancer invasion. Further animal studies are needed to understand their role in cancer progression and metastasis for targeted therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Rho GTPases regulate critical cellular processes like migration, phagocytosis, and cell cycle progression.
  • They influence the expression of genes involved in cancer invasion, such as matrix-degrading proteases.
  • Elevated Rho family member expression and mutations in regulators are observed in human cancers, suggesting therapeutic potential.

Purpose of the Study:

  • To investigate the role of Rho proteins in cancer cell proliferation, survival, invasion, and metastasis.
  • To evaluate the contribution of Rho GTPase signaling pathways to cancer progression using animal models.

Main Methods:

  • The study likely involved analyzing Rho protein expression and activity in cancer models.
  • Investigating the effects of modulating Rho signaling on cancer cell behavior in vivo.
  • Utilizing genetic or pharmacological approaches to target Rho pathways in animal cancer models.

Main Results:

  • Preliminary findings suggest Rho GTPases are implicated in cancer cell proliferation and survival.
  • Evidence indicates Rho proteins contribute to cancer cell invasion and metastasis.
  • Animal studies are crucial for validating these roles and exploring therapeutic strategies.

Conclusions:

  • Rho GTPase signaling pathways represent promising therapeutic targets for cancer treatment.
  • Further research, particularly in animal models, is essential to fully elucidate the contribution of Rho proteins to cancer.
  • Understanding Rho protein functions in cancer progression can lead to novel anti-cancer drug development.

More Related Videos

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...